PMID- 35181747 OWN - NLM STAT- MEDLINE DCOM- 20220310 LR - 20220310 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 12 IP - 1 DP - 2022 Feb 18 TI - Association between depression and anxiety on symptom and function after surgery for lumbar spinal stenosis. PG - 2821 LID - 10.1038/s41598-022-06797-1 [doi] LID - 2821 AB - Evidence on the role of depression and anxiety in patients undergoing surgical treatment for symptomatic degenerative lumbar spinal stenosis (DLSS) is conflicting. We aimed to assess the association between depression and anxiety with symptoms and function in patients undergoing surgery for DLSS. Included were patients with symptomatic DLSS participating in a prospective multicentre cohort study who underwent surgery and completed the 24-month follow-up. We used the hospital anxiety and depression scale (HADS) to assess depression/anxiety. We used mixed-effects models to quantify the impact on the primary outcome change in the spinal stenosis measure (SSM) symptoms/function subscale from baseline to 12- and 24-months. Logistic regression analysis was used to quantify the odds of the SSM to reach a minimal clinically important difference (MCID) at 24 months follow-up. The robustness of the results in the presence of unmeasured confounding was quantified using a benchmarking method based on a multiple linear model. Out of 401 patients 72 (17.95%) were depressed and 80 anxious (19.05%). Depression was associated with more symptoms (beta = 0.36, 95% confidence interval (CI) 0.20 to 0.51, p < 0.001) and worse function (beta = 0.37, 95% CI 0.24 to 0.50, p < 0.001) at 12- and 24-months. Only the association between baseline depression and SSM symptoms/function was robust at 12 and 24 months. There was no evidence for baseline depression/anxiety decreasing odds for a MCID in SSM symptoms and function over time. In patients undergoing surgery for symptomatic DLSS, preoperative depression but not anxiety was associated with more severe symptoms and disability at 12 and 24 months. CI - (c) 2022. The Author(s). FAU - Held, U AU - Held U AD - Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland. FAU - Burgstaller, J M AU - Burgstaller JM AD - Department of Internal Medicine, Horten Centre for Patient Oriented Research and Knowledge Transfer, University of Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. AD - Institute of Primary Care, University and University Hospital Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. FAU - Deforth, M AU - Deforth M AD - Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland. FAU - Steurer, J AU - Steurer J AD - Department of Internal Medicine, Horten Centre for Patient Oriented Research and Knowledge Transfer, University of Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. FAU - Pichierri, G AU - Pichierri G AD - Department of Internal Medicine, Horten Centre for Patient Oriented Research and Knowledge Transfer, University of Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. AD - Institute of Primary Care, University and University Hospital Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. FAU - Wertli, M M AU - Wertli MM AD - Department of Internal Medicine, Horten Centre for Patient Oriented Research and Knowledge Transfer, University of Zurich, Pestalozzistrasse 24, 8032, Zurich, Switzerland. Maria.Wertli@insel.ch. AD - Department of General Internal Medicine, Kantonsspital Baden, Im Ergel 1, 5404, Baden, Switzerland. Maria.Wertli@insel.ch. AD - Division of General Internal Medicine, Bern University Hospital, University of Bern, Freiburgstrasse 16p, 3010, Bern, Switzerland. Maria.Wertli@insel.ch. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220218 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 SB - IM MH - Aged MH - Anxiety Disorders/*epidemiology/etiology/pathology/psychology MH - Decompression, Surgical/adverse effects MH - Depression/*epidemiology/etiology/pathology/psychology MH - Disabled Persons MH - Female MH - Follow-Up Studies MH - Humans MH - Logistic Models MH - Lumbar Vertebrae/pathology/*surgery MH - Male MH - Middle Aged MH - Minimal Clinically Important Difference MH - Spinal Stenosis/*complications/pathology/psychology/surgery MH - Treatment Outcome PMC - PMC8857319 COIS- The authors declare no competing interests. EDAT- 2022/02/20 06:00 MHDA- 2022/03/11 06:00 PMCR- 2022/02/18 CRDT- 2022/02/19 05:29 PHST- 2021/06/05 00:00 [received] PHST- 2022/01/31 00:00 [accepted] PHST- 2022/02/19 05:29 [entrez] PHST- 2022/02/20 06:00 [pubmed] PHST- 2022/03/11 06:00 [medline] PHST- 2022/02/18 00:00 [pmc-release] AID - 10.1038/s41598-022-06797-1 [pii] AID - 6797 [pii] AID - 10.1038/s41598-022-06797-1 [doi] PST - epublish SO - Sci Rep. 2022 Feb 18;12(1):2821. doi: 10.1038/s41598-022-06797-1.